Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-03-19
2011-10-04
Cordero Garcia, Marcela M (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
08030279
ABSTRACT:
The present invention is directed to a compound of Formula I wherein R1, R2, R3, R4, R5, R6, W, X, Y, and Z are defined herein. The compounds of the present invention are useful as anticancer agents. Specifically, the compounds are useful for treating or preventing cancer and tumor growth. The present invention is also directed to compositions comprising a compound according to the above formula. The present invention is also directed to methods of using a compound according to the above formula.
REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4493796 (1985-01-01), Rinehart, Jr.
patent: 4782135 (1988-11-01), Rinehart, Jr.
patent: 5137870 (1992-08-01), Rinehart
patent: 5504189 (1996-04-01), Emling et al.
patent: 6509315 (2003-01-01), Joullié et al.
patent: 7064105 (2006-06-01), Joullié et al.
patent: 7122519 (2006-10-01), Joullié et al.
patent: 7651997 (2010-01-01), Joullié et al.
patent: 7678265 (2010-03-01), Fabrell
patent: 7737114 (2010-06-01), Joullie et al.
patent: 2003/0104991 (2003-06-01), Joullie et al.
patent: 2007/0129289 (2007-06-01), Joullie et al.
patent: 2 102 322 (1997-07-01), None
patent: WO 98/17275 (1998-04-01), None
patent: WO 98/17302 (1998-04-01), None
patent: WO 01/76616 (2001-10-01), None
patent: WO 02/02596 (2002-01-01), None
Liang et al. Total Synthesis of [(2S)-Hiv2]Didemnin M. J Org Chem, 2000, vol. 65, pp. 4762-4765.
Bren. Fluorescent and photochromic chemosensors. Russian Chemical Reviews. 2001. vol. 70, No. 12, pp. 1017-1036.
Bundgaard, H.,Design of Prodrugspp. 7-9, 21-24, Elsevier Science Publishers B.V., The Netherlands (1985).
Depenbrock, et al., “In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells,”Brit. J. Cancer 78:739-744, Cancer Research Campaign, UK (1998).
Grubb, et al., “Didemnin B induces cell death by apoptosis: the fastest induction of apoptosis ever described,”Biochem. Biophys. Res. Commun. 215:1130-1136, Academic Press, Inc., United States (1995).
Johnson, et al., “Protein tyrosine kinase inhibitors prevent didemnin B-induced apoptosis in HL-60 cells,”FEBS Lett. 383:1-5, Federation of European Biochemical Societies, UK (1996).
Johnson, et al., “Rapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: Evidence for the possible involvement of FK506-binding protein 25,”Immunol. Cell Biol. 77:242-248, Nature Publishing Group, United States (1999).
Johnson, et al., “Unspecific Activation of Caspases During the Induction of Aapoptosis by Didemnin B in Human Cell Lines,”J. Cell. Biochem. 72:269-278, Wiley-Liss, Inc., United States (1999).
Li, at al., “Total Synthesis and Structural Investigations of Didemnins A, B, and C,”J. Am. Chem. Soc. 112:7659-7672, American Chemical Society, United States (1990).
Liang, et al., “The First Total Synthesis of (−)—Tamandarin A,”Org. Lett. 1:1319-1322, American Chemical Society, United States (1999).
Liang, et al., “Total Synthesis of [(2S)-Hiv2]Didemnin M,”J. Org. Chem. 65:4762-4765, American Chemical Society, United States (2000).
Liang, at al., “Total Syntheses and Biological Investigations of Tamandarins A and B and Tamandarin A Analogs,”J. Am. Chem. Soc. 123:4469-4474, American Chemical Society, United States (2001).
MacLean, et al., “Glossary of Terms Used in Combinatorial Chemistry,”Pure Appl. Chem. 71:2349-2365, IUPAC, United States (1999).
Petit & Larcheveque, “Ethyl Glycidate from (S)-Serine; Ethyl (R)-(+)-2,3-Epoxypropanoate (Oxiranecarboxylic acid, ethyl ester, (R)−),”Organic Syntheses vol. 75, pp. 37-44, ed. Amos B. Smith, III, John Wiley & Sons, Inc, United States (1998).
Pfizenmayer, et al., “Synthesis and Biological Activity of [Tic5] Didemnin B,”Bioorg. Med. Chem. Lett. 8:3653-3656, Elsevier Science Ltd., UK (1998).
Sakai, at al., “Structure-Activity Relationships of the Didemnins1,2”J. Med. Chem. 39:2819-2834, American Chemical Society, United States (1996).
Skehan, et al., “New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening,”J. Natl. Cancer Inst. 82:1107-1112, Oxford University Press, United States (1990).
International Search Report for International Application No. PCT/US04/08275, United States Patent and Trademark Office, United States, mailed on Aug. 9, 2005, published Oct. 6, 2005.
Nakamura, et al., “Dehydrooligopeptides. XVII. Practical Synthesis of All of the Diastereomers of N,N-Protected 2,3-Diaminobutanoic Acids from L- and D-Threonine Derivatives,”Bull. Chem. Soc. Jpn 68:1369-1377, The Chemical Society of Japan, Japan (1995).
Sifferlen, T., at al., “ β-Thiopeptides: Synthesis, NMR Solution Structure, CD Spectra and Photochemistry,”Helv. Chim. Acta 82:2067-2093, Neue Schweizerische Chemische Gesellschaft, Switzerland (1999).
Shalaby, M.A, et al., “Thiopeptide Synthesis. α-Amino Thionoacid Derivatives of Nitrobenzotriazole as Thioacylating Agents,”J. Org. Chem. 61:9045-9048, American Chemical Society, United States (1996).
Sakai, R., et al., “Seven New Didemnins from the Marine TunicateTrididemnum solidum,” J. Am. Chem. Soc. 117:3734-3748, American Chemical Society, United States (1995).
Hossain, M. B, et al., “Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptide,”Proc. Natl. Acad. Sci. USA 85:4118-4122, National Academy of Sciences, United States (1988).
Roush, W.R., et al., “Design, Synthesis and Evaluation of D-Homophenylalanyl Epoxysuccinate Inhibitors of the Trypanosomal Cysteine Protease Cruzain,”Tetrahedron 56:9747-9762, Elsevier Science Ltd., UK (2000).
Armstrong, R.N., “Nucleophilic Epoxide Openings,”Comprehensive Natural Products Chemistry vol. 5, pp. 51-70, ed. C. Dale Poulter, Elsevier Science, Ltd., UK (1999).
Wróblewski, A.E. & Balcerzak, K.B., “Synthesis of diethyl (1R,2R)- and (1S,2R)-3- acetamido-1,2-dihydroxypropylphosphonates,”Tetrahedron: Asymmetry 13:845-850, Elsevier Science Ltd., UK (2002).
Lindberg, J., et al., “Efficient Synthesis of Phospholipids from Glycidyl Phosphates,”J. Org. Chem. 67:194-199, American Chemical Society, United States (2002).
Sata, N.U., et al., “Synthesis of all isomers of pulcherrimine, a bitter principle in the sea urchin ovary,”Tetrahedron Letters 43:115-118, Elsevier Science Ltd., UK (2002).
Kwon, S. J. & Ko, S.Y., “Synthesis of statine employing a generalsyn-amino alcohol building block,”Tetrahedron Letters.. 43:639-641, Elsevier Science Ltd., UK (2002).
Koviach, J. L., et al., “Design and Synthesis of Conformationally Constrained Glycosylated Amino Acids,”J. Org. Chem.66:2318-2326, American Chemical Society, United States (2001).
Gravier-Pelletier, C., et al., “Liposidomycins—Synthetic Studies Towards the Ribosyldiazepanone Moiety,”Eur. J. Org. Chem. 16:3089-3096, Wiley-VCH Verlag GmbH, Germany (2001).
Bardi, R., et al., “Molecular and Crystal Structures of Three Monothiated Analogues of the Terminally Blocked Ala-Aib-Ala Sequence of Peptaibol Antiobiotics,”Bipolymers 27:747-761, John Wiley & Sons, Inc., United States (1988).
Meyer, J.-P., et al., “Synthesis Using a Fmoc-Based Strategy and Biological Activites of Some Reduced Peptide Bond Pseudopeptide Analogues of Dynorphin A1,”J. Med. Chem. 38:3462-3468, American Chemical Society, United States (1995).
Tran, T. T., et al., “Effects of Thioamide Substitutions on the Conformation and Stability of α-and 310-Helices,”J. Am. Chem. Soc. 124:5222-5230, American Chemical Society, United States (2002).
Gauthier, J.Y & Lebel, H., “A remarkably simple conversion of nitriles to thioamides,”Phosph
Cordero Garcia Marcela M
Sterne Kessler Goldstein & Fox P.L.L.C.
The Trustees of the University of Pennsylvania
LandOfFree
Tamandarin analogs and fragments thereof and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tamandarin analogs and fragments thereof and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tamandarin analogs and fragments thereof and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280516